Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy

NCT06096870 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

65

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer
Recurrent Prostate Cancer
PET Positive

Interventions

DRUG: Enzalutamide
DRUG: PDS01ADC

Sponsor

National Cancer Institute (NCI)